Eaton Vance Management Novartis Ag Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Novartis Ag stock. As of the latest transaction made, Eaton Vance Management holds 293,532 shares of NVS stock, worth $28.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

293,532

Previous 296,040 0.85%

Holding current value

$28.7 Million

Previous $25 Million 10.84%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $187,121 - $218,848	-2,508 Reduced 0.85%	293,532 $22.3 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $1.25 Million - $1.46 Million	-15,583 Reduced 5.0%	296,040 $25 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $4.51 Million - $5.11 Million	56,343 Added 22.07%	311,623 $27.3 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $931,055 - $1.03 Million	11,682 Added 4.8%	255,280 $21.8 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $441,039 - $513,090	-5,393 Reduced 2.17%	243,598 $19.4 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $1.2 Million - $1.33 Million	-14,083 Reduced 5.35%	248,991 $22.7 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $1.85 Million - $2.19 Million	-22,201 Reduced 7.78%	263,074 $22.5 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $90,092 - $108,972	1,154 Added 0.41%	285,275 $26.9 Million
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $236,645 - $262,171	2,881 Added 1.02%	284,121 $24.7 Million
Q2 2020 Nov 20, 2020	SELL	$80.93 - $91.1 $17,561 - $19,768	-217 Reduced 0.08%	281,240 $24.6 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $263,265 - $296,348	-3,253 Reduced 1.14%	281,457 $24.6 Million
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $335,470 - $470,000	-4,747 Reduced 1.64%	284,710 $23.5 Million
Q4 2019 Feb 11, 2020	BUY	$84.35 - $95.37 $384,214 - $434,410	4,555 Added 1.6%	289,457 $27.4 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $995,001 - $1.1 Million	11,632 Added 4.26%	284,902 $24.8 Million
Q2 2019 Nov 21, 2019	SELL	$75.4 - $92.8 $58,661 - $72,198	-778 Reduced 0.28%	273,270 $25 Million
Q2 2019 Aug 16, 2019	SELL	$75.4 - $92.8 $7.04 Million - $8.67 Million	-93,393 Reduced 25.42%	274,048 $25 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $21,842 - $24,983	290 Added 0.08%	367,441 $35.3 Million
Q4 2018 Feb 07, 2019	BUY	$73.66 - $82.02 $7.03 Million - $7.82 Million	95,400 Added 35.11%	367,151 $31.5 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $27,847 - $32,210	416 Added 0.15%	271,751 $23.4 Million
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $433,598 - $490,044	-6,680 Reduced 2.4%	271,335 $20.5 Million
Q1 2018 May 07, 2018	SELL	$70.39 - $84.15 $471,190 - $563,300	-6,694 Reduced 2.35%	278,015 $22.5 Million
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $2,097 - $2,251	-29 Reduced 0.01%	284,709 $23.9 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $21.1 Million - $22 Million	284,738	284,738 $24.4 Million

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $210B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Novartis Ag Transaction History